Borouge to Build Second Plant in China

Borouge, a leading provider of innovative plastics solutions, announced its intention to build a second manufacturing plant in China at the signing of an agreement with the Nansha Municipal Government on May 28, 2010.

Speaking at the signing ceremony in Guangzhou,China, William Yau, CEO of Borouge's Marketing Company said: "It is our intention to be a reliable supplier to the rapidly growing automotive and appliance industries in China and therefore we have decided to invest in a second compounding plant that produces tailor-made resins in close proximity to our customers."

This announcement closely follows the inauguration of Borouge's first compounding plant in Shanghai on April 20, 2010, and presents the opportunity for the company to strengthen its presence in China. Construction work on the plant is expected to be completed by the middle of 2012. Provision will be made to produce up to 105,000 tonnes of compounded polypropylene resins annually. The new compounding plant will also benefit from the Application Research and Development Centre being established in Shanghai and the Innovation Centre being built in Abu Dhabi, UAE.

Borouge's commitment to China is further underlined by the set of its Guangzhou office in the beginning of 2010, and its logistics hub located in the Nansha district of Guangzhou.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Borouge. (2019, February 10). Borouge to Build Second Plant in China. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=21778.

  • MLA

    Borouge. "Borouge to Build Second Plant in China". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=21778>.

  • Chicago

    Borouge. "Borouge to Build Second Plant in China". AZoM. https://www.azom.com/news.aspx?newsID=21778. (accessed November 21, 2024).

  • Harvard

    Borouge. 2019. Borouge to Build Second Plant in China. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=21778.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.